×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
QURE – uniqure n.v. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
QURE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/14
08:42 am
qure
uniQure (NASDAQ:QURE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Medium
Report
uniQure (NASDAQ:QURE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
1/12
11:11 am
qure
QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Low
Report
QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
1/12
10:33 am
qure
Is UniQure (QURE) One of the Promising Stocks to Buy Under $50? [Yahoo! Finance]
Low
Report
Is UniQure (QURE) One of the Promising Stocks to Buy Under $50? [Yahoo! Finance]
1/11
01:03 am
qure
uniQure (NASDAQ:QURE) was downgraded by analysts at Wall Street Zen
Medium
Report
uniQure (NASDAQ:QURE) was downgraded by analysts at Wall Street Zen
1/9
07:05 am
qure
uniQure Announces Type A Meeting Scheduled with FDA
Medium
Report
uniQure Announces Type A Meeting Scheduled with FDA
1/8
04:46 pm
qure
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Medium
Report
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
1/7
05:56 pm
qure
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Low
Report
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
1/5
06:00 pm
qure
QURE Investigation: Investors Encouraged to Contact Kirby McInerney LLP
Low
Report
QURE Investigation: Investors Encouraged to Contact Kirby McInerney LLP
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
07:05 am
qure
uniqure n.v. - ordinary shares
MISS
Report
-2.2%
uniqure n.v. - ordinary shares
7/29/2025
07:05 am
qure
uniqure n.v. - ordinary shares
BEAT
Report
-3.6%
uniqure n.v. - ordinary shares
5/9/2025
07:05 am
qure
uniqure n.v. - ordinary shares
BEAT
Report
4.2%
uniqure n.v. - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/14
04:26 pm
qure
Form 4 uniQure N.V. For: Jan 12 Filed by: Gut Robert
Neutral
Report
Form 4 uniQure N.V. For: Jan 12 Filed by: Gut Robert
1/13
07:05 am
qure
Form 8-K uniQure N.V. For: Jan 13
Medium
Report
Form 8-K uniQure N.V. For: Jan 13
1/12
04:21 pm
qure
Form 4 uniQure N.V. For: Jan 09 Filed by: Kaye Jack
Medium
Report
Form 4 uniQure N.V. For: Jan 09 Filed by: Kaye Jack
1/12
04:00 pm
qure
Form 144 uniQure N.V. Filed by: Gut Robert
Medium
Report
Form 144 uniQure N.V. Filed by: Gut Robert
1/9
04:00 pm
qure
Form 144 uniQure N.V. Filed by: Kaye Jack
Medium
Report
Form 144 uniQure N.V. Filed by: Kaye Jack
1/9
07:06 am
qure
Form 8-K uniQure N.V. For: Jan 09
Medium
Report
Form 8-K uniQure N.V. For: Jan 09
12/4
07:06 am
qure
Form 8-K uniQure N.V. For: Dec 04
High
Report
Form 8-K uniQure N.V. For: Dec 04
11/14
04:12 pm
qure
Form SCHEDULE 13G/A uniQure N.V. Filed by: Vestal Point Capital, LP
Low
Report
Form SCHEDULE 13G/A uniQure N.V. Filed by: Vestal Point Capital, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.
11.2%
6/16 UniQure NV weighs options including sale -Bloomberg [Reuters] 11.2%
10/25 Form 4 uniQure N.V. For: Oct 23 Filed by: Kapusta Matthew C 7.0%
5/10 uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B 7.0%
6/11 Uniqure NV (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at Janney Montgomery Scott. 5.9%
3/24 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.2%
1/31 Form 4 uniQure N.V. For: Jan 31 Filed by: van Deventer Sander 5.1%
5/16 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.3%
5/21 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 3.9%
4/24 Form 4 uniQure N.V. For: Apr 22 Filed by: Kapusta Matthew C 3.8%
6/16 UniQure NV weighs options including sale -Bloomberg [Reuters] 11.2%
10/25 Form 4 uniQure N.V. For: Oct 23 Filed by: Kapusta Matthew C 7.0%
5/10 uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B 7.0%
6/11 Uniqure NV (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at Janney Montgomery Scott. 5.9%
3/24 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.2%
1/31 Form 4 uniQure N.V. For: Jan 31 Filed by: van Deventer Sander 5.1%
5/16 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.3%
5/21 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 3.9%
4/24 Form 4 uniQure N.V. For: Apr 22 Filed by: Kapusta Matthew C 3.8%
TOP News Decliners
9/4
uniQure Announces Proposed Public Offering
-14.9%
5/12 Uniqure NV (NASDAQ: QURE) was given a new $81.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock. -7.0%
2/25 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.6%
7/29 Q2/2019 6/30/2019 EPS -0.830 ZacksConsensus N/A ActVsEst N/A - N/A -6.2%
9/5 uniQure Announces Pricing of its Public Offering -6.1%
3/6 Form 3/A uniQure N.V. For: Aug 07 Filed by: KLEMT CHRISTIAN -5.8%
1/29 Form 4 uniQure N.V. For: Jan 27 Filed by: Gut Robert -5.8%
3/2 Form 424B5 uniQure N.V. -5.6%
8/23 Form 4 uniQure N.V. For: Aug 21 Filed by: Kapusta Matthew C -5.0%
5/1 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $71.00 price target on the stock. -4.9%
5/12 Uniqure NV (NASDAQ: QURE) was given a new $81.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock. -7.0%
2/25 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.6%
7/29 Q2/2019 6/30/2019 EPS -0.830 ZacksConsensus N/A ActVsEst N/A - N/A -6.2%
9/5 uniQure Announces Pricing of its Public Offering -6.1%
3/6 Form 3/A uniQure N.V. For: Aug 07 Filed by: KLEMT CHRISTIAN -5.8%
1/29 Form 4 uniQure N.V. For: Jan 27 Filed by: Gut Robert -5.8%
3/2 Form 424B5 uniQure N.V. -5.6%
8/23 Form 4 uniQure N.V. For: Aug 21 Filed by: Kapusta Matthew C -5.0%
5/1 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $71.00 price target on the stock. -4.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: